First Quarter 2024 Operating Revenues:  $491.9 million, up 12.5%First Quarter 2024 Operating Income:  $75.1 million, up $36.9 millionFirst Quarter 2024 Earnings Per Share:  $1.99 per share, up $1.04 per shareDeclares Quarterly Dividend:  $0.105 per shareWARREN, Mich., April 25, 2024 /PRNewswire/ -- Universal Logistics Holdings, Inc. (NASDAQ: ULH) today reported consolidated first quarter 2024 net income of $52.5 million, or $1.99 per basic and diluted share, on total operating revenues of $491.9 million. This compares to net income of $24.9 million, or $0.95 per basic and diluted share, during first quarter 2023 on total operating revenues of $437.4 million.

iSun, Inc. (NASDAQ: ISUN) (the “Company,” or “iSun”), a leading solar energy and clean mobility infrastructure company with 50-years of experience accelerating the adoption of innovative electrical technologies, announced today that its Board of Directors has approved the rescission of the previously announced reverse stock split.

Mobix Labs, Inc. (Nasdaq: MOBX) (“Mobix Labs” or the “Company”), a fabless semiconductor company developing disruptive next-generation connectivity solutions for wired, wireless 5G, military, defense, aerospace, and medical industries, will release its second quarter 2024 financial results after U.S. markets close on Tuesday, May 14, 2024. Mobix Labs, Inc. management will host a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss its business and financial performance.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the American Society of Gene & Cell Therapy (ASGCT) has accepted 20 Sangamo abstracts for presentation at the 27th ASGCT Annual Meeting being held May 7-11, 2024, in-person in Baltimore, MD and in a virtual format. Presentations will focus on the progression of Sangamo’s neurology-focused pre-clinical pipeline, including data supporting innovations in zinc finger epigenetic regulation, advances in AAV capsid engineering, and discovery of next-generation integrase technology.